Trial Profile

A novel approach to assess gastrointestinal adverse effects of opioids

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 31 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naloxone/oxycodone (Primary) ; Oxycodone
Indications Intestinal disorders
Focus Therapeutic Use

Most Recent Events

14 Oct 2022 Results comparing regional transit times in patients with CP to those in healthy controls, and investigating whether they were associated with diabetes mellitus, exocrine dysfunction, opioid treatment or quality of life, published in the Medicine
10 Oct 2017 New trial record
06 Oct 2017 Results published in the Digestive Diseases and Sciences

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com